Day: December 2, 2019

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATESVANCOUVER, British Columbia, Dec. 02, 2019 (GLOBE NEWSWIRE) — Lumina Gold Corp. (TSXV: LUM) (OTCQX: LMGDF) (the “Company” or “Lumina”) is pleased to announce that it plans to conduct a non-brokered private placement of up to approximately 16.0 million common shares of Lumina (the “Shares”) at a price of C$0.50 per Share to raise gross proceeds of up to approximately C$8.0 million (the “Offering”). Ross J. Beaty has agreed to subscribe for C$4.7 million of the private placement. Assuming the Offering size is exactly C$8.0 million and Mr. Beaty subscribes for C$4.7 million of the Offering, Mr. Beaty’s ownership of Lumina will increase from 17.95% to 19.93% on a non-diluted basis.The net proceeds of the Offering will be used to fund study...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATESVANCOUVER, British Columbia, Dec. 02, 2019 (GLOBE NEWSWIRE) — Luminex Resources Corp. (TSXV: LR) (US OTC: LUMIF) (the “Company” or “Luminex”) is pleased to announce that it plans to conduct a non-brokered private placement of up to approximately 19.2 million common shares of Luminex (the “Shares”) at a price of C$0.52 per Share to raise gross proceeds of up to approximately C$10.0 million (the “Offering”). Ross J. Beaty has agreed to subscribe for at least C$3.15 million of the private placement. Assuming the Offering size is exactly C$10.0 million and Mr. Beaty subscribes for C$3.15 million of the Offering, Mr. Beaty’s ownership of Luminex will increase from 15.6% to 19.9% on a non-diluted basis.The net proceeds of the Offering will be...

TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — FirstService Corporation (TSX: FSV; NASDAQ: FSV) (“FirstService”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and TD Securities Inc., under which the underwriters have agreed to buy on a bought deal basis 2,165,000 common shares (the “Common Shares”) of FirstService, at a price of US$92.50 per Common Share for gross proceeds of approximately US$200 million (the “Offering”). FirstService has granted the underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any. The offering is expected to close on or about December 13, 2019 and is subject to receipt of all necessary regulatory...

PHOENIX, Dec. 02, 2019 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) announced today that under the recent amendment to its agreement with American Airlines, the company did not meet certain performance metrics during the most recent measurement period, which allows American to remove two additional aircraft from the capacity purchase agreement. American has agreed to defer the right to remove these two aircraft but has elected to remove one of two previously deferred aircraft, effective January 2, 2020.Based on the increased utilization of the remaining fleet, fiscal Q2 2020 (ending March 31) block hours for American are expected to be within one percent of block hour production for the same period last year.About Mesa Air Group, Inc.Headquartered in Phoenix, Arizona, Mesa Air Group, Inc. is the holding company of Mesa...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 02, 2019 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that Theresa Heah, M.D., Chief Medical Officer, has resigned from the company to pursue other opportunities.Given that the clinical results for the upcoming data releases are still being processed at external vendors and not yet available for internal review, Dr. Heah’s resignation does not relate to any knowledge of pending results. Dr. Heah has agreed to stay with the company until the end of the year to support the up-coming data analysis. In addition, Dr. Heah’s departure does not affect the company’s previously announced guidance on the...

PRINCETON, N.J., Dec. 02, 2019 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Clearway Energy”) today announced that it has commenced an underwritten public offering of 5,405,405 shares of its Class C common stock. Clearway Energy intends to use the net proceeds from the offering to acquire newly issued Class C units of Clearway Energy LLC (“Clearway LLC”).  Clearway Energy intends to cause Clearway LLC to use such proceeds to partially fund the acquisition of the 527 megawatt Carlsbad Energy Center from an affiliate of Global Infrastructure Partners III (“GIP”), pay transaction fees and expenses and use the balance of the proceeds, if any, for general corporate purposes.RBC Capital Markets, LLC will act as the sole book runner for the offering.A shelf registration statement (including a prospectus) relating to...

Paris, 02 December 2019, 10.15pmSummary of webcast with Key Opinion Leaders on masitinibPhase 3 results in severe asthma uncontrolled by oral corticosteroidsAB Science SA (NYSE Euronext – FR0010557264 – AB) is providing a summary of the live webcast held on 02 December with key opinion leaders on severe asthma uncontrolled by oral corticosteroids (OCS) and the role that masitinib may play in treating this disorder.The presentation of the webcast is available on the company’s website.A replay of the webcast is available at the following address: Webcast ReplayExperts’ opinionMasitinib is a first in class oral drug in severe asthma, selectively targeting mast cells. There is a strong scientific rationale to target mast cells in asthma and study AB07015 was the first positive large-scale study in severe asthma utilizing a drug...

Paris, 2 décembre 2019, 22h15Résumé de la conférence web avec les principaux leaders d’opinion autourdes résultats de la phase 3 du masitinib dans l’asthme sévèrenon contrôlé par les corticostéroïdes orauxAB Science SA (NYSE Euronext – FR0010557264 – AB) fournit le résumé de la conférence web du 2 décembre sur l’asthme sévère non contrôlé par les corticostéroïdes oraux avec les principaux leaders d’opinion de cette maladie et sur le rôle du masitinib comme possible traitement dans cette indication.La présentation de la conférence web est disponible sur le site internet d’AB Science.Un replay audio de la conférence est disponible à l’adresse suivante : Replay webcastOpinion des principaux leaders d’opinionLe masitinib est un médicament administré par voie orale et pionnier dans le traitement de l’asthme sévère, qui cible...

TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Colliers International, leading global commercial real estate services and investment management firm (NASDAQ and TSX: CIGI), today announced its intention to build a market-leading presence across North Carolina by launching a new company-owned operation in Raleigh as a complement to its existing business in Charlotte. Colliers will not renew its license with its existing affiliate and will open new operations by the third quarter of 2020.J. Scott Adams, Colliers International Virginia | President will oversee the new operation in Raleigh, including efforts to identify a proven business leader and recruiting high-quality professionals in capital markets, leasing and property management.“Colliers enjoys a strong position in the Southeast and is deeply committed to North Carolina, one of...

MADISON, Wis., Dec. 02, 2019 (GLOBE NEWSWIRE) — The Madison Covered Call and Equity Strategy Fund (NYSE:MCN) (the “Fund”) declares its quarterly dividend of $0.18/share. The dividends will be payable December 30, 2019 to shareholders of record on December 17, 2019. The ex-dividend date will be December 16, 2019. If it is determined that a notification is required pursuant to Section 19(a) of the Investment Company Act of 1940, as amended, such notice will be posted to the Fund’s website after the close of business three business days before the payable date. If a distribution rate is largely comprised of sources other than income, it may not reflect Fund performance.The Fund’s objective is to achieve a high level of current income and current capital gains, with long-term capital appreciation as a secondary objective. The Fund intends...